Skip to main content

MJFF Publications

1631 - 1640 of 7785 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • RESTRICTED
    Title: Group Exercise Classes Are Fun and Motivating
    Journal Name: Brain & Life
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nnn.0000834396.10260.d4
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: How Flavonoids Affect Parkinson's Disease
    Journal Name: Brain & Life
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nnn.0000834392.64279.cf
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Immune responses in the Parkinson's disease brain
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2022.105700
    Citation Count: 35
  • RESTRICTED
    Title: Intracerebral administration of a modified antisense oligonucleotide targeting the dopamine system in a mouse model of Parkinson’s disease
    Journal Name: STAR Protocols
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.xpro.2022.101445
    Citation Count: 0
  • RESTRICTED
    Title: Issue Overview
    Journal Name: CONTINUUM: Lifelong Learning in Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/01.con.0000840008.09408.75
    Best OA location URL:
    Citation Count: 0
  • RESTRICTED
    Title: Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease
    Journal Name: Molecular Therapy - Nucleic Acids
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.omtn.2022.02.007
    Citation Count: 15
  • RESTRICTED
    Title: Molecular mechanisms defining penetrance of LRRK2-associated Parkinson’s disease
    Journal Name: Medizinische Genetik
    Publisher: Walter de Gruyter GmbH
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1515/medgen-2022-2127
    Citation Count: 0
  • RESTRICTED
    Title: Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
    Journal Name: International Journal of Molecular Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/ijms23116216
    Citation Count: 28
  • RESTRICTED
    Title: Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacement
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2022.104476
    Citation Count: 14
  • RESTRICTED
    Title: Perry Syndrome with Intrafamilial Heterogeneity in Presentation and Survival Including Acute Respiratory Failure: Case Series
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13473
    Citation Count: 2
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.